Valuation: Kilitch Drugs (India) Limited

Market Cap 6.78B 70.61M 61.57M 58.14M 52.79M 98.92M 99.33M 696M 269M 3.44B 265M 259M 11.08B P/E 2025
21.8x
P/E 2026 14.3x
Enterprise Value 6.98B 72.69M 63.39M 59.85M 54.35M 102M 102M 717M 277M 3.55B 273M 267M 11.41B EV / Sales 2025
2.88x
EV / Sales 2026 1.98x
Free-Float
28.24%
Yield 2025 *
-
Yield 2026 -
1 day+1.47%
1 week+3.47%
Current month+9.63%
1 month+10.93%
3 months+5.45%
6 months+19.84%
Current year+9.34%
1 week 185
Extreme 185
194
1 month 156
Extreme 156
194
Current year 117.25
Extreme 117.25
207.77
1 year 117.25
Extreme 117.25
219.5
3 years 111.78
Extreme 111.775
250
5 years 62.5
Extreme 62.5
250
10 years 16.15
Extreme 16.15
250
Manager TitleAgeSince
Chief Executive Officer 73 1992-05-11
Director of Finance/CFO 43 2021-02-28
Chief Operating Officer - 2021-03-31
Director TitleAgeSince
Chairman 73 -
Director/Board Member 50 2007-09-28
Director/Board Member 48 2014-09-29
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+3.47% - - 69.76M
-0.83%+2.45%+49.83%+100.09% 1,027B
0.00%+1.55%+54.86%+66.00% 651B
-0.01%+2.66%+18.90%+71.46% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+0.78%+1.44%+38.78%+45.46% 205B
+0.79%+1.84%-28.27%-56.71% 190B
-0.12%+4.70%+32.43%+98.98% 187B
Average +0.03%+2.49%+25.90%+45.02% 400.23B
Weighted average by Cap. -0.31%+2.62%+34.73%+61.24%

Financials

2025 2026
Net sales 1.98B 20.67M 18.02M 17.02M 15.45M 28.95M 29.07M 204M 78.66M 1.01B 77.64M 75.92M 3.24B 2.35B 24.54M 21.4M 20.21M 18.35M 34.38M 34.52M 242M 93.4M 1.2B 92.18M 90.14M 3.85B
Net income 267M 2.78M 2.43M 2.29M 2.08M 3.9M 3.91M 27.44M 10.59M 136M 10.45M 10.22M 437M 302M 3.14M 2.74M 2.59M 2.35M 4.4M 4.42M 31.01M 11.97M 153M 11.81M 11.55M 493M
Net Debt -99.42M -1.04M -903K -853K -775K -1.45M -1.46M -10.22M -3.94M -50.54M -3.89M -3.81M -163M 200M 2.08M 1.81M 1.71M 1.56M 2.92M 2.93M 20.53M 7.92M 102M 7.82M 7.64M 327M
Logo Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.
Employees
236
Date Price Change Volume
26-09-18 191.45 +1.47% 13,725
26-09-17 ₹188.67 -0.08% 18,618
26-09-16 ₹188.82 -0.73% 9,185
26-09-15 ₹190.20 +2.27% 28,652
26-09-11 ₹185.97 +0.51% 22,611
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!